Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
≥99%(HPLC) for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Protected from light,Store at -20°C,Desiccated Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 33 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Hoechst 33258 is a nuclear staining reagent that can penetrate cell membranes and stain DNA. It releases strong blue fluorescence after intercalating double-stranded DNA. Hoechst 33258 is often used for cell apoptosis detection. After staining, observe with a fluorescence microscope or detect with a flow cytometer. The excitation and emission wavelengths of Hoechst 33258-DNA are 352 nm and 461 nm, respectively.
Instructions
1. For fixed cells or tissues
1) For cell or tissue samples, after fixation, wash them appropriately to remove fixative. Then, if immunofluorescence staining is required, perform immunofluorescence staining first, and then follow the subsequent steps for Hoechst 33258 staining after the staining is completed. If no other staining is required, the subsequent Hoechst 33258 staining is directly performed.
2) For adherent cells or tissue sections, add a small amount of Hoechst 33258 staining solution to cover the sample. For suspended cells, add at least 3 times the volume of the sample to be stained with staining solution and mix well. Leave at room temperature for 3-5 minutes.
3) Aspirate the Hoechst 33258 staining solution, wash 2-3 times with TBST, PBS or saline, 3-5 minutes each time.
4) Observe directly under a fluorescence microscope or after mounting the slide. When observing cell apoptosis, the nucleus of apoptotic cells will be densely stained, or fragmented and densely stained.
2. For living cells or tissues
5) Add an appropriate amount of Hoechst 33258 staining solution, which must fully cover the sample to be stained. Usually, 1ml staining solution is needed for one well of a six-well plate, and 100 microliters of staining solution is required for one well of a 96-well plate.
6) Incubate for 20-30 minutes at a temperature suitable for cell culture. Discard the staining solution, wash 2-3 times with PBS or culture solution to perform fluorescence detection.
Storage conditions: Store at -20°C and protected from light, valid for one year.
Precautions
1) Hoechst 33258 is irritating to the human body, please pay attention to proper protection.
2) Fluorescent dyes have the problem of quenching. It is recommended to complete the test on the same day after dyeing.
3) To slow down fluorescence quenching, anti-fluorescence quenching mounting solution can be used.
4) For your safety and health, please wear lab coats and disposable gloves for operation.
| Pubchem Sid | 504753482 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504753482 |
| Sonrisas canónicas | CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)O.Cl.Cl.Cl |
| IUPAC Name | 4-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]phenol;trihydrochloride |
| InChIKey | SMNPLAKEGAEPJD-UHFFFAOYSA-N |
| INCHI | 1S/C25H24N6O.3ClH/c1-30-10-12-31(13-11-30)18-5-9-21-23(15-18)29-25(27-21)17-4-8-20-22(14-17)28-24(26-20)16-2-6-19(32)7-3-16;;;/h2-9,14-15,32H,10-13H2,1H3,(H,26,28)(H,27,29);3*1H |
| Isómeros SMILES | CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)O.Cl.Cl.Cl |
| WGK Alemania | 3 |
| RTECS | SM1140500 |
| PubChem CID | 31953 |
| Peso molecular | 533.90 |
| Beilstein | 4088183 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Clase | Benzimidazoles |
| Subclass | Phenylbenzimidazoles |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Phenylbenzimidazoles |
| Alternative Parents | N-arylpiperazines Phenylimidazoles Dialkylarylamines N-methylpiperazines 1-hydroxy-2-unsubstituted benzenoids Benzene and substituted derivatives Heteroaromatic compounds Trialkylamines Azacyclic compounds Organooxygen compounds Hydrochlorides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Phenylbenzimidazole - N-arylpiperazine - 2-phenylimidazole - Dialkylarylamine - Tertiary aliphatic/aromatic amine - 1-hydroxy-2-unsubstituted benzenoid - Phenol - N-alkylpiperazine - N-methylpiperazine - Monocyclic benzene moiety - 1,4-diazinane - Benzenoid - Piperazine - Azole - Heteroaromatic compound - Imidazole - Tertiary aliphatic amine - Tertiary amine - Azacycle - Hydrochloride - Organooxygen compound - Organonitrogen compound - Hydrocarbon derivative - Organic oxygen compound - Organic nitrogen compound - Amine - Aromatic heteropolycyclic compound |
| Descripción | This compound belongs to the class of organic compounds known as phenylbenzimidazoles. These are compounds containing a phenylbenzimidazole skeleton, which consists of a benzimidazole moiety where its imidazole ring is attached to a phenyl group. |
| External Descriptors | Not available |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Fecha | Articulo |
|---|---|---|---|
| Certificate of Analysis | Apr 03, 2026 | H266330 | |
| Certificate of Analysis | Apr 03, 2026 | H266330 | |
| Certificate of Analysis | Apr 02, 2026 | H266330 | |
| Certificate of Analysis | Jan 20, 2026 | H266330 | |
| Certificate of Analysis | Feb 06, 2025 | H266330 | |
| Certificate of Analysis | Jun 09, 2022 | H266330 |
| Sensibilidad | Light & Heat sensitive |
|---|---|
| Punto de fusión (°C) | 314°C |
| Peso molecular | 533.900 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 532.131 Da |
| Monoisotopic Mass | 532.131 Da |
| Topological Polar Surface Area | 84.100 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 634.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 4 |
| 1. Weiyuan Ma, Xiuwen Zhang, Le Zhuang. (2023) Exogenous Hydrogen Sulfide Induces A375 Melanoma Cell Apoptosis Through Overactivation of the Unfolded Protein Response. Clinical Cosmetic and Investigational Dermatology, [PMID:37396710] [10.2147/CCID.S412588] |
| 2. Yingying Zhang, Tiange Wang, Yinping Zhuang, Tiandi He, Xiaoli Wu, Lin Su, Jun Kang, Jin Chang, Hanjie Wang. (2021) Sodium Alginate Hydrogel-Mediated Cancer Immunotherapy for Postoperative In Situ Recurrence and Metastasis. ACS Biomaterials Science & Engineering, [PMID:34757733] [10.1021/acsbiomaterials.1c01216] |
| 3. Yunran Zhang, Haiping Zhou, Zhe Zhang, Yijun Zhu, Tao Wang, Liguo Yu, Hongrui Song. (2020) Redox/NIR dual-responsive PEG-betulinic acid/pluronic-cypate prodrug micelles for chemophotothermal therapy. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, [PMID:] [10.1016/j.colsurfa.2020.125662] |
| 4. Chenglong Ma, Wei Sun, Waqas Qamar Zaman, Zhenhua Zhou, Hao Zhang, Qicheng Shen, Limei Cao, Ji Yang. (2020) Lanthanides Regulated the Amorphization–Crystallization of IrO2 for Outstanding OER Performance. ACS Applied Materials & Interfaces, [PMID:32658446] [10.1021/acsami.0c08969] |
| 5. Zhang Tao, Jiang Zhenqi, Chen Libin, Pan Chunshu, Sun Shan, Liu Chuang, Li Zihou, Ren Wenzhi, Wu Aiguo, Huang Pintong. (2020) PCN-Fe(III)-PTX nanoparticles for MRI guided high efficiency chemo-photodynamic therapy in pancreatic cancer through alleviating tumor hypoxia. Nano Research, 13 (1): (273-281). [PMID:] [10.1007/s12274-019-2610-6] |
| 6. Jun Dai, Yinghao Li, Zi Long, Ruming Jiang, Zeyan Zhuang, Zhiming Wang, Zujin Zhao, Xiaoding Lou, Fan Xia, Ben Zhong Tang. (2019) Efficient Near-Infrared Photosensitizer with Aggregation-Induced Emission for Imaging-Guided Photodynamic Therapy in Multiple Xenograft Tumor Models. ACS Nano, [PMID:31820925] [10.1021/acsnano.9b07972] |
| 7. Tao Zhang, Zhenqi Jiang, Ting Xve, Shan Sun, Juan Li, Wenzhi Ren, Aiguo Wu, Pintong Huang. (2019) One-pot synthesis of hollow PDA@DOX nanoparticles for ultrasound imaging and chemo-thermal therapy in breast cancer. Nanoscale, 11 (45): (21759-21766). [PMID:31482919] [10.1039/C9NR05671H] |
| 8. Hailing Yang, Zhenjie Liu, Yonglong Song, Changjiang Hu. (2019) Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis. DRUG DELIVERY, [PMID:31389248] [10.1080/10717544.2019.1636423] |
| 9. Zigui Wang, Gaizhen Kuang, Zhiqiang Yu, Aimin Li, Dongfang Zhou, Yubin Huang. (2019) Light-activatable dual prodrug polymer nanoparticle for precise synergistic chemotherapy guided by drug-mediated computed tomography imaging. Acta Biomaterialia, [PMID:31128323] [10.1016/j.actbio.2019.05.047] |
| 10. Zhao Shuai, Sun Shan, Jiang Kai, Wang Yuhui, Liu Yu, Wu Song, Li Zhongjun, Shu Qinghai, Lin Hengwei. (2019) In Situ Synthesis of Fluorescent Mesoporous Silica–Carbon Dot Nanohybrids Featuring Folate Receptor-Overexpressing Cancer Cell Targeting and Drug Delivery. Nano-Micro Letters, 11 (1): (1-13). [PMID:34137970] [10.1007/s40820-019-0263-3] |
| 11. Rui Wang, Xing Hu, Junhui Pan, Guowen Zhang, Deming Gong. (2019) Interaction of isoeugenol with calf thymus DNA and its protective effect on DNA oxidative damage. JOURNAL OF MOLECULAR LIQUIDS, [PMID:] [10.1016/j.molliq.2019.03.018] |
| 12. Jie Li, Suqin Shen, Fei Kong, Ting Jiang, Cui Tang, Chunhua Yin. (2018) Effects of pore size on in vitro and in vivo anticancer efficacies of mesoporous silica nanoparticles. RSC Advances, 8 (43): (24633-24640). [PMID:35539161] [10.1039/C8RA03914C] |
| 13. Jie-Hua Shi, Yan-Yue Lou, Kai-Li Zhou, Dong-Qi Pan. (2018) Exploration of intermolecular interaction of calf thymus DNA with sulfosulfuron using multi-spectroscopic and molecular docking techniques. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, [PMID:29935392] [10.1016/j.saa.2018.06.054] |
| 14. Ying Wang, Yating Zhao, Yu Cui, Qinfu Zhao, Qiang Zhang, Sara Musetti, Karina A Kinghorn, Siling Wang. (2017) Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers. Acta Biomaterialia, [PMID:29037897] [10.1016/j.actbio.2017.10.025] |
| 15. Huanan Wang, Wenqing Xu. (2017) Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, [PMID:28546001] [10.1016/j.bbrc.2017.05.116] |
| 16. Hongxia Liu, Shuqin Wu, Jingmou Yu, Dun Fan, Jin Ren, Lei Zhang, Jianguo Zhao. (2017) Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin. Materials Science & Engineering C-Materials for Biological Applications, [PMID:28415498] [10.1016/j.msec.2017.02.030] |
| 17. Huanan Wang, Ming Yao, Wenqing Xu. (2016) The antitumor effects of mitochondria-targeted 6-(nicotinamide) methyl coumarin. Open Life Sciences, 11 (1): (542-551). [PMID:] [10.1515/biol-2016-0070] |
| 18. Haibo Mu, Qianjin Liu, Hong Niu, Dongdong Wang, Jiangjiang Tang, Jinyou Duan. (2015) Autophagy promotes DNA–protein crosslink clearance. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, [PMID:26921017] [10.1016/j.mrgentox.2015.12.001] |
| 19. Li Jingchao, Wang Tingting, Shi Yuanfei, Ye Zichen, Zhang Xun, Ming Jiang, Zhang Yafei, Hu Xinyan, Li Yun, Zhang Dongsheng, Xu Qianhe, Yang Jun, Chen Xiaolan, Liu Nian, Su Xinhui. (2024) A continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy. JOURNAL OF NANOBIOTECHNOLOGY, 22 (1): (1-15). [PMID:38166931] [10.1186/s12951-023-02268-5] |
| 20. Yanghui Chen, Yuan Li, Junliang Luo, Zixin Li, Yu Huang, Jia Cai, Dongneng Jiang, Defeng Zhang, Jichang Jian, Jun Qiang, Bei Wang. (2024) A novel study of brain microvascular endothelial cells induced by astrocyte conditioned medium for constructing blood brain barrier model in vitro: A promising tool for meningitis of teleost. FISH & SHELLFISH IMMUNOLOGY, [PMID:38266792] [10.1016/j.fsi.2024.109401] |
| 21. Ouyang Boshu, Shan Caihua, Shen Shun, Dai Xinnan, Chen Qingwang, Su Xiaomin, Cao Yongbin, Qin Xifeng, He Ying, Wang Siyu, Xu Ruizhe, Hu Ruining, Shi Leming, Lu Tun, Yang Wuli, Peng Shaojun, Zhang Jun, Wang Jianxin, Li Dongsheng, Pang Zhiqing. (2024) AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer. Nature Communications, 15 (1): (1-20). [PMID:39215014] [10.1038/s41467-024-51980-9] |
| 22. Zhang Hongmei, Yang Yunxia, Wang Yanqing. (2025) Comprehensive Investigations About the Binding Interactions of Sudan Dyes with DNA by Spectroscopy and Docking Methods. JOURNAL OF FLUORESCENCE, [PMID:39777621] [10.1007/s10895-024-04125-6] |
| 23. Ziwei Yan, Hui Zhang, Jinghao Chen, Qingqing Xu, Shuaipeng Feng, Qinfu Zhao, Siling Wang. (2024) Cu(II)-doped mesoporous polydopamine as biodegradable nanoplatforms for photothermal-enhanced multi-mode anti-tumor therapy. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, [PMID:] [10.1016/j.colsurfa.2024.133258] |
| 24. Jingmou Yu, Yifei Zhang, Meilin Xu, Dengzhao Jiang, Wenbo Liu, Hongguang Jin, Pu Chen, Jing Xu, Lei Zhang. (2024) Innovative gelatin-based micelles with AS1411 aptamer targeting and reduction responsiveness for doxorubicin delivery in tumor therapy. BIOMEDICINE & PHARMACOTHERAPY, [PMID:38513599] [10.1016/j.biopha.2024.116446] |
| 25. Xiaowen Liu, Huamei Cai, Liang Peng, Hongli Ma, Yun Yan, Weixia Li, Jing Zhao. (2024) Microglial Nrf2/HO-1 signaling gates remifentanil-induced hyperalgesia via suppressing TRPV4-mediated M1 polarization. FREE RADICAL BIOLOGY AND MEDICINE, [PMID:38295888] [10.1016/j.freeradbiomed.2024.01.047] |
| 26. CaoXiaona , LiJie , RenJinliang , PengJiajin , ZhongRuyue , HeJiahao , XuTing , YuZhenhua , JinHuawei , HaoSiqi , LiuRuiwei , XuBingzhe. (2024) Minimally-invasive implantable device enhances brain cancer suppression. EMBO Molecular Medicine, [PMID:38902433] [10.1038/s44321-024-00091-5] |
| 27. Hao Liu, Ke Huang, Hao Zhang, Xiaohui Liu, Hui Jiang, Xuemei Wang. (2024) Photo-Driven In Situ Solidification of Whole Cells through Inhibition of Trogocytosis for Immunotherapy. Research, [PMID:38384327] [10.34133/research.0318] |
| 28. Junhong Ling, Yingying Cai, Haozhan Feng, Zhen Liu, Xiao-kun Ouyang. (2024) Polydopamine-Modified Copper Coordination Mesoporous Silica Nanoparticles Loaded with Disulfiram for Synergistic Chemo-Photothermal Therapy. Pharmaceutics, 16 (4): (512). [PMID:38675173] [10.3390/pharmaceutics16040512] |
| 29. Zepeng Cui, Ruqian Ji, Jun Xie, Chao Wang, Jia Tian, Weian Zhang. (2024) Tumor Microenvironment-Triggered Self-Adaptive Polymeric Photosensitizers for Enhanced Photodynamic Therapy. BIOMACROMOLECULES, [PMID:38507248] [10.1021/acs.biomac.3c01150] |
| 30. Sijia Xiang, Zhuanghao Hou, Yu Wang, Yang Yang, Hongze Hu, Chang Yin, Guangming Huang, Kaiming Cao, Yangzhong Liu. (2025) Metal-induced nanoscale clusterization initiates protein liquid-liquid phase separation. Cell Reports, [PMID:40716064] [10.1016/j.celrep.2025.116067] |
| 31. Meng Lan, Fansu Meng, Lanwen Gao, Anil K. Giri, Makiya Nishikawa, Kosuke Kusamori, Jaiwoo Lee, Mulazim Hussain Asim, Shumaila Arshad, Honghui Gu, Qi Li, Lina Yang, Zhong Chen, Zhenjiang Yang, Jiajia Qin, Yu Cai. (2025) Preparation of baicalin nano prodrug and its effect on inhibiting metastasis of triple-negative breast cancer. Biomaterials Advances, [PMID:40850054] [10.1016/j.bioadv.2025.214464] |
| 32. Yaqian He, Zichuang Xu, Yaqian Yan, Jiajun Gao, Xuwu Zhang, Yuchu He, Qingzhi Luo, Desong Wang, Dawei Gao. (2025) ‘Pioneer’ T cells and ‘major force’ piezo-nanozymes synergize to achieve high-specificity targeted penetration and enhanced immunotherapy. JOURNAL OF COLLOID AND INTERFACE SCIENCE, [PMID:40966969] [10.1016/j.jcis.2025.139028] |
| 33. Yuze Luo, Ying Wang, Cheng Jin, Ke Yang, Zefeng Wang, Yinbang Zheng, Junqin Li, Chunlei Ou, Li Wang, Dinggeng He. (2026) pH-responsive tannic acid-iron nanozymes capable of self-adaptive regulation of oxidative stress for enhancing the treatment of MRSA-infected wound via disrupting PBP2a to restore methicillin sensitivity. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2026.173215] |